Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Abbott Australasia Pty Ltd Diagnostic Division

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (127)
Cancellation by sponsor (37)
COVID-19 test kit (3)

Date

2024 (4)
2023 (6)
2022 (9)
2021 (24)
2020 (20)
2019 (1)
2018 (20)
2017 (13)
2015 (5)
2014 (7)
2013 (26)
2012 (19)
2011 (12)
2010 (1)

Results for "[search-keyword]"

Search

Sponsor content

167 result(s) found, displaying 1 to 10

Abbott Australasia Pty Ltd Diagnostic Division - Clinical chemistry therapeutic drug monitoring IVDs (463246)

30 September 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Clinical chemistry therapeutic drug monitoring IVDs.
Abbott Australasia Pty Ltd Diagnostic Division - General laboratoryware IVDs Cancelled under Section 41GL(d) of the Act

28 June 2024

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Diagnostic Division
Abbott Australasia Pty Ltd Diagnostic Division - Biological stain IVDs Cancelled under Section 41GL(d) of the Act

28 June 2024

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Diagnostic Division
Abbott Australasia Pty Ltd Diagnostic Division - Histology and Cytology ancillary IVDs Cancelled under Section 41GL(d) of the Act

28 June 2024

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Diagnostic Division
Abbott Australasia Pty Ltd Diagnostic Division - Alinity s CMV IgG Qualitative Assay - Cytomegalovirus (CMV) immunoglobulin G (IgG) antibody IVD, kit, chemiluminescent immunoassay Cancelled under Section 41GL(d) of the Act

28 June 2023

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Diagnostic Division
Abbott Australasia Pty Ltd Diagnostic Division - Specimen receptacle IVDs Cancelled under Section 41GL(d) of the Act

23 June 2023

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Diagnostic Division
Abbott Australasia Pty Ltd Diagnostic Division - Clinical chemistry tumour marker IVDs Cancelled under Section 41GL(d) of the Act

1 June 2023

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Diagnostic Division
Abbott Australasia Pty Ltd Diagnostic Division - Multiple clinical chemistry constituent IVDs Cancelled under Section 41GL(d) of the Act

1 June 2023

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Diagnostic Division
Abbott Australasia Pty Ltd Diagnostic Division - Herpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs (393812)

11 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbott Australasia Pty Ltd Diagnostic Division - Herpes simplex virus (HSV) (Human herpesvirus 1 & 2) IVDs.
Abbott Australasia Pty Ltd Diagnostic Division - Instrument/analyser IVDs Cancelled under Section 41GL(d) of the Act

15 May 2023

Cancellation by sponsor

Requested by Abbott Australasia Pty Ltd Diagnostic Division

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.